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                                                      ABSTRACT 
TITLE OF THE ABSTRACT: CORRELATION BETWEEN CORD BLOOD 
INSULIN/IGF-1 AND EARLY POST NATAL GROWTH IN SMALL FOR 
GESTATIONAL AGE BABIES. 
DEPARTMENT: PEDIATRICS 
NAME OF THE CANDIDATE: ABHILASHA SMITH 
DEGREE AND SUBJECT: MD PEDIATRICS 
NAME OF THE GUIDE: DR SARAH MATHAI 
OBJECTIVES: To compare the levels of insulin, glucose and IGF-1 in term born AGA 
and SGA babies and demonstrate difference in IGF-1 and insulin resistance as measured 
by the HOMA-IR index. To demonstrate any difference in catch up growth in AGA and 
SGA babies and its correlation with diet and these hormonal parameters at 3.5 and 6 
months. 
METHODS: Maternal and Neonatal details were collected at birth and recorded. Cord 
blood samples for measurement of  glucose , insulin and IGF-1 were taken from 60 
infants(30 AGA and 30 SGA). Using this information, HOMA-IR was calculated. 
The cohort was followed up at 3.5 and 6 months and a growth assessment was done. The 
dietary history was also collected. Infants were categorized as adequately, inadequately 
and rapidly growing based on the catch up growth at 3.5 months in both the AGA and 
SGA arms. Glucose, insulin and IGF-1 levels were taken at 6 months. The hormonal 
profiles at birth and at 6 months were correlated to the growth rates. 
Data analysis was done using the SPSS version 21. The Mann whitney U test was used to 
compare the two groups. 
RESULTS: The SGA babies were lighter, shorter and had a smaller head circumference 
at birth compared to the AGA babies. The cord blood insulin (P=0.0002) and IGF-
1(<0.01) were higher in AGA group. There was a linear correlation between the birth 
weight and the cord blood insulin (p=0.01) and IGF-1(p<0.01).The growth velocity at 3.5 
months was similar between the AGA and SGA groups, however, the SGA babies 
continued to be shorter and lighter than the AGA ones. Insulin and IGF-1 levels at birth 
had no correlation with catch up growth. 
KEY WORDS: Small for gestational age, Insulin, IGF-1, Catch up growth. 
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1.INTRODUCTION 
The definition of  small for gestational age (SGA) includes babies whose birth weight or 
length is 2 standard deviation(<2SD) below the mean for age.(1)(2). The factors 
affecting size of babies at birth include maternal factors like age, parity, chronic 
illnesses and nutritional status, placental factors like structural abnormalities and 
placental insufficiency and fetal factors like genetic syndromes and chromosomal 
anomalies.(1),(3),(4). There is compelling evidence from numerous epidemiological 
studies showing an association between intrauterine growth restriction and an 
increased risk of adult diseases.. These include short stature, hypertension, lipid 
disorders, impaired glucose tolerance, type 2 diabetes and cardiovascular 
disease.(5),(6),(7),(8).The “Barker hypothesis” proposes that the increased risk of 
later adult diseases in those born with low birth weight originates through adaptations 
of the fetus when it is undernourished.(7),(9). These adaptations can be metabolic, 
endocrine or cardiovascular and may permanently change the structure and function 
of the body through changes in insulin metabolism and body fat distribution.(10). 
Among the factors which affect the intrauterine growth of the fetus, maternal nutrition is 
probably the most important one . Hormones which play a key role in  fetal growth are 
insulin and insulin like growth factor (IGF) system(11). 
. Insulin is the key regulator of IGF-1 during the intrauterine life. While IGF-2 affects the 
embryonic growth, IGF-1 is the major growth regulator in late gestation.(12). Low levels 
of IGF-1 and IGF-2 are reported in the cord blood samples of SGA infants.(5).Nutrition 
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seems to play a major role in the postnatal regulation of IGF-1 in early infancy.(13) 
Thereafter by 6-12 months   growth hormone(GH) and IGF-1 levels rise leading on to 
catch up growth.(5). Therefore most of the post natal growth occurs in a GH dependent 
fashion. Catch up growth usually occurs in the first 6 months and is completed by 2 years 
of age.(12). It is postulated that the risk of later adult diseases is higher in infants who 
showed rapid catch up growth.(14)As the physical activity is fairly similar in children 
between 0-6 months of age, diet and hormonal milieu play an important role in their 
growth during this period. 
India has probably the largest number of low birth weight (LBW) babies in the world and 
from the Mysore and Pune data, we know that Indian babies have a “thin-fat” phenotype, 
which predisposes them to an unfavourable metabolic profile in adulthood.(15),(16). 
There are only few longitudinal studies from India assessing the serial changes in 
hormonal profile and catch up growth in SGA babies. Therefore we planned  this study to 
compare the hormonal milieu and catch up growth of  SGA and AGA infants between 
birth and 6 months of age.  
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2.AIMS AND OBJECTIVES 
1. To compare  the levels of insulin, glucose, and IGF-1 at birth in term born AGA and 
SGA infants and demonstrate difference ,if any, in the IGF-1 levels as well as insulin 
resistance as measured by HOMA-IR index. 
2.To demonstrate the difference in catch up growth in SGA and AGA infants at 3 
months of age and its correlation with diet.  
3. To demonstrate the difference in catch up growth in SGA and AGA infants at 6 
months of age and its correlation with  
a. increments in IGF-1 level and HOMA-IR .  
b. diet  in the first 6 months of life  
4. To demonstrate the correlation between weight and height gain at 6 months 
independently with IGF-1 level. 
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SECTION 1: 
DEFINITIONS RELATED TO BIRTH & BIRTH WEIGHT USED IN THIS 
STUDY 
The definitions used for the various terms related to birth and birth weight in this study 
are as follows:  
Term birth is defined as delivery between 37 to 42 completed weeks of gestation. 
 Low birth weight (LBW) is defined as birth weight <2500 gm.  
Small for gestational age (SGA) is defined as birth weight less than the 10th percentile 
of the index population„s distribution of birth weights by gestation i.e. the lowest 10% of 
birth weights (ref Peter Lee et al 2001).  The reference for this study is  taken from a 
recent publication of  the  birth weight centile charts from rural community based data in 
southern India.(17).   
Appropriate for gestational age (AGA)is defined as birth weight between the 10
th
 and 
90
th
 centile for gestational age  as per the reference above(17). 
CATCH UP GROWTH is defined as the infant reaching a length and weight =/>the 
third percentile(-2SD).(3).A change in Z score ≥0.67 can also be considered as catch 
up.(18). 
Postnatal growth was evaluated for the first 3 months after birth. The terms related 
to postnatal growth used in this study are as follows: 
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ADEQUATELY GROWING: During the first 3 months, if the infant has the expected 
weight gain of 20-30gms/day, length gain of 3.5cm/month and an increase in head 
circumference of  2cm/month the infant is considered to be growing adequately.(19) 
INADEQUATELY GROWING: During the first 3 months, if the infant‟sweight gain is 
<20gms/day, length increase is < 3.5cm/month and increase in head circumference is  
<2cm/month then the infant is considered as showing inadequate growth.. 
RAPIDLY GROWING: During the first 3 months, if the infant‟s weight gain is 
>30gms/day, length increase  > 3.5cm/month and increase in head circumference  
>2cm/month then the infant is considered to have rapid growth. 
The definition of adequate growth has been taken from the Nelson‟s Textbook of 
Pediatrics, 19
th
 edition. 
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SECTION 2: 
 
REDUCED INSULIN SENSITIVITY AND COMPENSATORY 
HYPERINSULINAEMIA- THE LINK BETWEEN LBW AND DISEASES OF 
METABOLIC SYNDROME: 
 
One of the most consistent findings in those who were born SGA was a reduction in 
insulin sensitivity.  This  has been demonstrated in all age groups from birth to adulthood 
(20),(21),(22).  . It  appears that reduced insulin sensitivity occurs early and probably in 
utero in SGA subjects.(23).  
Insulin sensitivity is defined as the ability of insulin to stimulate tissue glucose uptake 
and suppress endogenous glucose production. To maintain euglycaemia in the presence 
of reduced insulin sensitivity, the pancreatic ß cells increase insulin secretion resulting in 
compensatory hyperinsulinaemia. Eventually the pancreas cannot compensate any further 
and type 2 diabetes mellitus manifests.  
  
In an elegant study by Martin et al where they followed up a cohort for 25 years ,the 
predictive power of isolated insulin resistance was well  documented.(24). In 155 subjects 
followed up with intravenous glucose tolerance test(IVGTT) for 6-25 years they 
demonstrated that an isolated reduction in insulin sensitivity had a 40% cumulative risk 
of development of diabetes in first degree relatives of type 2 diabetics as compared to a 
17 
 
risk of less than 5% with those having normal insulin sensitivity . This is summarized in 
the figure below.(Figure 1). 
 
This graph shows the cumulative risk of Type 2 Diabetes Mellitus according to insulin 
sensitivity and glucose effectiveness.(Adpated from Martin BC, Lancet 1992 Oct 
17;340(8825)925-9) 
Although elevated insulin levels  ensures euglycaemia, the chronic hyperinsulinaemic 
state has adverse effects on other organ systems. The role of insulin in the pathogenesis 
of type 2 diabetes mellitus , hypertension  and cardiovascular diseases  has been well 
documented .  
Facchini et al categorized 208 healthy adult subjects into those with normal, moderate 
and marked insulin resistance using insulin suppression tests. Over a period of 4-11 years 
those with moderate or marked insulin resistance had a marked increase in the rate of 
type 2 diabetes mellitus as well as other diseases like hypertension, coronary heart 
disease, cerebrovascular accidents and even cancer,(25).  None of these events occurred 
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in the most insulin-sensitive tertile as compared to 28 clinical events in 25 individuals of 
the least insulin sensitive tertile. In this study insulin resistance was noted to be an 
independent predictor of all the 5 clinical events. This is summarized below in the figure 
below. 
 
 
Figure2. Long term risks of insulin resistance (Adapted from Facchini FS et al. JCEM 
2001; 3574-78 . 
 
Among the major lifestyle factors which affect insulin sensitivity are diet and exercise 
(26). Unhealthy diet includes high carbohydrate, habitual high fat and low fibre diets as 
well as excessive fast food consumption and these have all been independently shown to 
be associated with insulin resistance (27). Sedentary lifestyle including  physical 
inactivity, snacking during TV watching etc also contribute to obesity and adversely 
affect insulin sensitivity. These are modifiable risk factors.    
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SECTION 3: 
FETAL GROWTH, HORMONAL REGULATION AND CATCH UP GROWTH: 
 
Intrauterine growth occurs in  three distinct phases: (5) 
5)1)The first 16 weeks is a period of cell hyperplasia. 
2)16-32 weeks is a period of cell hyperplasia and hypertrophy 
3)The final growth phase from 32-40 weeks consists of rapid cellular hypertrophy(5). 
 
Normal intrauterine growth and size at birth depends upon the interaction between 
various maternal, genetic, hormonal and environmental factors.(5)(3). Of these perhaps 
the most important are the maternal factors which include maternal undernutrition, 
illnesses such as preeclampsia, infections, andtoxins such as cigarette smoke, alcohol. 
Maternal nutrition plays a key role in the fetal growth. While undernutrition  in early 
pregnancy results in symmetric or proportionate SGA babies, undernutrition in late 
pregnancy results in asymmetric SGA babies. Placental insufficiency including 
abruption, infarction and infection also affect fetal growth adversely.  
 
The genetic factors which affect fetal growth include  parental height, maternal age 
,congenital malformations and chromosomal anomalies(3)..The insulin and IGF system 
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plays an important  role in fetal growth. Environmental factors include maternal health 
and nutritional status. 
Hormones also play a major  role in fetal growth and is discussed next. 
HORMONAL REGULATION OF FETAL GROWTH 
Unlike postnatal growth the hormones which play a major role in the regulation of fetal 
and placental growth and development are  insulin and insulin like growth factor (IGF) 
system which includes IGF-1,IGF-2 and the IGF binding proteins IGFBP-1, IGFBP-2 
and IGFBP3.(28). These peptide hormones bind to specific receptor tyrosine kinases on 
the target tissues and bring about a variety of metabolic effects. Together they form the 
IGF axis which is responsive to a variety of environmental stimuli like nutrient and 
oxygen delivery.(29).  
IGF-2 primarily affects embryonic growth while IGF-1 promotes fetal growth in the late 
gestation.(12), (30),(31),(32).IGF-1 is produced by the fetal liver and its important 
actions are promotion of substrate uptake by the fetus, inhibition of catabolism and 
placental lactate production. Thus it helps in the nutrient supply to the placenta and the 
fetus. The predominant regulator of fetal IGF-1 production is fetal insulin which in turn is 
regulated by the fetal glucose availability. This is in contrast to postnatal growth where 
IGF-1 secretion is primarily mediated by growth hormone.  
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The IGF-1 system regulates fetal growth in response to nutrient availability, which means 
that in conditions of maternal malnutrition there is decrease in fetal growth with low 
levels of fetal IGF-1 and altered IGF binding proteins.(12). 
Insulin facilitates fetal  growth by its direct action on lipogenesis thereby increasing fetal 
adiposity . It also exerts its action indirectly by stimulating the  IGF-1 . IGF-2 has dual 
actions. Binding to the IGF-1 receptor brings about its biological actions which includes 
embryonic growth, while binding to the IGF-2 receptor decreases the circulating levels of 
IGF-2.Thus the IGF-2 receptor acts as a clearance receptor . 
In experimental knock out models it has been shown that deletion of the IGF-1 gene leads 
to severe IUGR. In case of IGF-2, knock out of the IGF-2 receptor leads to embryonic 
overgrowth while knock out of IGF-2 leads to poor embryonic growth.(12)(5). 
Thus, in instances of IUGR, the sensitivity  of the fetal tissue to IGF-1 appears to be 
disturbed. It has also been observed that cord blood levels of  IGF-1 and 2 are lower in 
SGA babies compared to babies born appropriate for gestational age(AGA)(11),(33).The 
terms intrauterine growth retardation (IUGR) and small for gestational age(SGA) are 
often used interchangeably, however they are not synonymous. 
IUGR describes a condition where there is failure of the fetus to reach its genetic growth 
potential.(34).  It can be symmetric, where all the fetal organs are proportionately 
decreased as a result of an insult during early gestation or asymmetric where the 
abdominal viscera and subcutaneous tissue experience a greater decrease in size 
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compared to the  size of the brain.(5).This process occurs later during gestation and 
demonstrates the ability of the fetus to adapt to an unfavourable environment by 
redistribution of blood flow to the vital organs. 
On the other hand, SGA describes a baby whose birth weight or length is less than 2 
standard deviations below the mean for age.(1).However there is much overlap between 
the two conditions. 
Therefore size at birth is not always an indicator of the fetal growth trajectory. Fetuses 
which have  intrauterine growth deceleration , may either result in SGA babies or they 
may show catch-up growth and be born  with appropriate birth weight. Thus birth weight 
is not a true index of fetal well being.. 
THE NUTRIENT PIPELINE AND FETAL RESPONSES TO A DISTURBED 
PIPELINE 
After birth, the levels of IGF-I and GH rise significantly in most SGA babies and are 
probably responsible for the catch-up growth.Maternal health and homeostasis, utero 
placental blood flow and metabolism affect the supply of nutrients to the growing 
fetus.(12). Parental ages, severe maternal exercise in the late trimester, cardiac disease 
and chronic infections play a significant role in fetal growth. The placenta in itself is 
metabolically active and consumes 40-60% of the glucose and oxygen extracted from the 
maternal circulation. 
23 
 
In IUGR, the level of this extraction rises further leading on to fetal malnutrition. If the 
amount of glucose available to the fetus is decreased, the insulin and IGF-1 levels decline 
and growth is affected. In the presence of uteroplacental disease, there is a redistribution  
of blood flow to the brain, heart, adrenals and placenta leading on to asymmetrical pattern 
of fetal growth. 
CONSEQUENCES IN INFANTS BORN SMALL FOR GESTATIONAL AGE( 
Importance of size at birth) 
In the late 1980s Professor Barker and his colleagues in Southampton made landmark 
observations linking LBW with adult onset diseases like coronary heart disease, type 2 
diabetes, chronic bronchitis, hypertension, stroke and hyperlipidemia(35). . These 
observations were subsequently  confirmed by several epidemiological studies from 
across the world thereby suggesting a relationship between early life events such as 
intrauterine growth restriction and later adult diseases.(7),(8).These initial studies led to 
the proposition of the Barker hypothesis„ which suggested that adverse events in utero 
leading to reduced fetal growth, permanently alter the structure and physiology of the 
offspring, such that the risk of heart disease and diabetes in later life was increased(36).  
There is now overwhelming evidence that early life events have persistent, long lasting 
consequences and these effects have been best described in term LBW subjects. 
During“critical periods” of  fetal development the fetal tissues grow by rapid cell 
division. Different organ systems have different critical periods. Barker proposed that any 
adverse intrauterine environment, for example, insufficient nutrition or oxygenation 
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during these critical periods results in fetal survival adaptations(37).These adaptations 
include alterations in the growth rates of the various organ systems such as to favour 
brain development at the expense of the less important abdominal organs and skeletal 
muscle. These adaptations result in variable phenotypes depending on the timing of the in 
utero insult. Late in utero nutritional insufficiency results in infants with LBW and 
disproportionate head size, length and weight. In contrast, proportionately small babies 
are likely to have faced undernutrition during early gestation. Programming is defined as 
the event/ events occurring during a critical period of development of the organism 
resulting in long term changes in its structure and function. Programming therefore forms 
the basis for the association between intrauterine adversity and increased risk of later 
diseases.  
 Programming results in fetal   adaptations which can be metabolic, endocrine or 
cardiovascular and may permanently change the structure and function of the body 
through changes in insulin metabolism and body fat distribution.(10). 
Several mechanisms have been proposed to explain fetal programming. According to the 
―thrifty genotype‖ hypothesis proposed by Neel in 1962, during times of insufficient 
nutrient supply, thrifty genes are selected in the fetus which cause a fast insulin trigger‖ 
and enhanced capacity to store fat, which in later life increases the risk of obesity and 
type 2 diabetes mellitus(38). Hales et al proposed the thrifty phenotype‖ hypothesis which 
stated  that during conditions of adverse intrauterine environment the fetus undergoes 
certain adaptations to ensure growth of vital body organs like brain at the expense of 
25 
 
other ”non essential„ organs(39). These adaptations may subsequently become 
detrimental if the postnatal environment is discordant with that in utero .(14),(40). 
The “ fetal salvage hypothesis” proposed that peripheral insulin resistance develops in 
the undernourished fetus which reduces the number and function of peripheral 
glucosetransporters (41). After birth persistent insulin resistance causes compensatory 
hyperinsulinaemia; progressive ß cell exhaustion eventually leading to ß cell failure and 
type 2 diabetes mellitus. 
THE “FETAL INSULIN” HYPOTHESIS developed by Hattersley and Tooke 
proposed that glucose sensing, insulin secretion and insulin resistance in the fetus are 
genetically mediated(42). The polygenic genetic factors that increase insulin resistance 
both in utero  
as well as in adult life would produce 2 phenotypes- a small thin baby as well as an adult 
with insulin resistance, hypertension, atherosclerosis and type 2 diabetes mellitus, 
particularly when associated with obesity. 
In 2004 Barker proposed the term “developmental plasticity”  to explain the 
developmental origins of adult disease. According to this theory, the fetus undergoes 
adaptations in utero to suit a predicted postnatal environment and when the postnatal 
environment is different from that which was predicted in utero the individuals may be at 
risk of adverse outcome(43).  Gluckman et al proposed the term ―predictive adaptive 
response‖(PAR) wherein during periods of developmental plasticity, the fetus makes 
adaptations which need not necessarily have immediate benefit but is made in expectation 
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of a future environment.(44). If the predicted and the actual future environment are 
similar these predictive adaptive responses are appropriate and facilitate survival. 
However if there is a mismatch between these two environments these PAR increase the 
risk of later diseases.  
 
Thus, when there is an abundance of  nutrition in post natal life as opposed to the 
“famine” in utero, the underlying insulin resistance predisposes the individual to an 
increased risk of developing type 2 diabetes mellitus,  hyperlipidemia etc. Similarly 
cardiovascular changes also occur in response to fetal stress and persist in adult life 
leading on to complications like hypertension and coronary artery disease.(45). These 
effects are  augmented by rapid catch up growth. 
Let us look at the effect of fetal programming on some of the major organ systems of the 
body. 
CARDIOVASCULAR SYSTEM: 
Many studies have shown an association between IUGR and cardiovascular 
complications in later life. Other than low birth weight, 3 factors play a role in the 
development of hypertension. 
Firstly, accelerated catch up growth is postulated to increase the risk(7). 
Secondly, altered angiotensin activity during fetal programming(7) and 
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Finally, increased catecholamine production and proliferation of renin producing 
juxtaglomerular cells(7) 
It is postulated that the cardiovascular remodeling which occurs as a stress response in 
utero persists in adult life leading on to a dilated cardiomyopathy like heart remodeling, 
vascular dysfunction and hypertension .(45)(9). 
ENDOTHELIAL DYSFUNCTION 
Fetal growth restriction leads to increase in the lipid concentrations and increased 
sympathetic tone. Also there is reduction in IGF-1 levels which might cause vessel wall 
thickening.(7). 
According to recent work done by Skilton and coworkers in 2007 comparing the aortic 
intima media thickness(aIMT)of infants with low birth weight with normal controls, it 
was found that the aIMT was greater in IUGR infants than normal controls.(46). 
Similarly, carotid wall thickness was shown to be higher in IUGR infants by Crispi et 
al.(47). This change persisted into adulthood. The  increase in arterial wall thickness was 
postulated to be a result of vascular remodeling occurring in fetal life. 
RENAL CONSEQUENCES 
It has been shown that IUGR infants have reduced number of nephrons at birth.(7). 
This leads to a decrease in the glomerular filtration surface area. The glomerular filtration 
rate is thereby maintained by increase in the renal blood flow which in turn causes 
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glomerular hypertension and hypertrophy (hyperfiltration hypothesis by Brenner and 
coworkers). In 2005,Keijzer and Veen showed a positive correlation between birth 
weight and GFR, at the same time a negative correlation between creatinine levels and 
birth weight.(48). Therefore it was suggested that the risk of hypertension and renal 
failure was higher in IUGR individuals. 
NEURODEVELOPMENTAL OUTCOMES 
Poor academic performance, cognitive impairment, behavioural problems, language and 
visuomotor impairment and learning difficulties are some of the neuropsychiatric issues 
reported in subjects born SGA(7). 
CATCH UP GROWTH- THEORIES AND IMPLICATIONS 
Catch up growth is defined as the infant reaching a length and weight =or>the third 
percentile (-2SD).(3). Catch up growth usually starts early after birth and is completed by 
2 years of age.(1). About 10-15% of children born SGA fail to achieve to catch up 
growth.(5).  
Karlberg has designed the infancy-childhood-puberty growth model based on normal 
growth among infants. Growth is divided into 3 phases. 
1) The infancy phase begins in mid gestation and lasts upto 3 years of age. This phase 
represents the postnatal continuation of fetal growth. 
2) The childhood phase begins from 6-12 months of age till puberty. 
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3) The pubertal phase starts from puberty until the attainment of the final height. 
Growth hormone (GH) begins to exert its action from 6-12 months of age(5). This leads 
to a rise in the GH dependent IGF-1 production, leading to increase in the growth 
velocity. 
SGA infants show the maximum catch up growth during the first 6 months of life. Those 
who fail to show catch up by 6 months , are postulated to suffer from difficulty in 
transition to the GH dependent growth or malfunction of the GH-IGF-1 axis.Infants born 
small for gestational age have lower levels of insulin and IGF-1.It is postulated that in 
tissues chronically deprived and depleted of these, a substantial  rise in concentration 
during rapid catch-up growth leads to early development of insulin resistance.(5). 
Those infants who show early and complete recovery in form of rapid catch up growth 
are at the highest risk of metabolic disturbances.(1),(49). 
 
There are 2 models proposed for governing catch up growth:(5),(50). 
1) The neuroendocrine model: This states that each individual has a genetically 
programmed age appropriate set point for body proportions. This mechanism situated in 
the central nervous system is able to judge the mismatch between the actual and target 
size and adjust the growth rate accordingly. 
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2)The growth plate model:  This model suggests that growth is a localized process 
occurring at the individual growth plates as is evidenced by local catch up growth after 
transient suppression of growth at a particular growth plate. 
However neither of the two can completely explain the underlying mechanisms of catch 
up growth. 
Thus one can conclude  that catch up growth depends upon genetic, nutrirional and 
hormonal factors especially the GH-IGF-1 axis. Children who fail to show catch up 
growth may have a persistent defect in the GH-IGF-1 axis. 
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SECTION 4: 
STUDIES RELATED TO THIS THESIS 
 
1.SIZE AT BIRTH AND CORD BLOOD LEVELS OF INSULIN, IGF-1 AND 
OTHER HORMONES IN TERM HUMANS INFANTS. 
 
IGF axis plays a major role in fetal growth , therefore cord blood insulin and IGF-1 levels 
are expected to correlate with the birth size. In an African American and White cohort,  
Vidal et al (51)observed  that infants with higher IGF-1 levels were larger at birth 
(p=0.0001) after adjusting for factors like, race, gender, gestational age at delivery, 
maternal BMI and smoking. In this study a strong positive correlation was also found 
between infants with high IGF-1 levels and maternal obesity  (BMI>30 kg/m2). 
 Maternal obesity drives the fetal IGF axis and increases the risk of higher birth weight 
and childhood obesity. 
Smerieriet al observed (52) a positive effect of cord blood IGF-2 on birth weight and 
length whereas IGFBP-2 had a negative effect on both birth weight and height. 
Other parameters such as  insulin, cortisol and IL-6 did not seem to have a major role in 
determining birth size in this study. 
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Ken Ong and co-workers studied the correlation between size at birth and cord blood 
levels of Insulin,IGF-1,IGF-2,IGFBP-1 and 3 and the soluble IGF-2 binding 
receptor.(53). A total of 199 term newborns were studied.  
It was found that insulin, IGF-1 and IGFBP-3 were positively related to birth weight and 
ponderal index. Positive correlation was also found between the IGF2/IGF-2 R ratio with 
all parameters at birth. 
Akcakus et al looked at the relationship between intrauterine growth, IGF-1 and IGFBP-3 
and bone mineral status in newborn babies.(54) 
IGF-1 levels were noted to be  highest in LGA followed by AGA and SGA babies 
(p<0.01). 
Karamizadeh etal observed that in addition to cord blood IGF-1, maternal IGF-1 and 
cortisol levels were also low in SGA babies.  
Similarly, adipose tissue hormone, adiponectin was also  noted to be low in SGA babies 
at birth.(55).Similar to other studies, these investigators also reported a positive 
correlation of IGF-1 level and birth weight. 
An Indian study was done by SubarnaMitra etal to look at how fetal growth was affected 
by maternal anthropometry and metabolic profile.(56). 
The mean level of cord blood insulin was higher in LGA when compared to SGA babies. 
(p 0.007). Birth weight was correlated with maternal weight (p 0.0002) and maternal BMI 
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(p 0.0001). Also cord blood insulin had a positive correlation with all anthropometric 
parameters at birth except ponderal index and chest circumference. 
Claudio Chiesa while confirming a positive correlation of IGF-1 and IGFBP-3 with all 
anthropometric measurements at birth observed that ghrelin and insulin had no 
correlation with the birth measurements(57), whereas., leptin levels were found to have a 
trend towards a positive correlation with the birth length. (p=0.05). 
 
2.GENDER SPECIFICITY OF INSULIN, INSULIN LIKE GROWTH FACTOR-1 
AND OTHER HORMONES ON PRENATAL GROWTH 
 
Lourdes Ibanezetal observed that (58) the cord insulin and IGF-1 were higher in term 
girls when compared to term boys both in the SGA and AGA group(p<0.01) concluding  
that these hormones were gender specific . 
However in a  similar study  done by SubarnaMitra etal in India.(59), no gender based 
differences in the anthropometry and cord blood insulin in term Indian could be 
demonstrated. 
In a recent Indian study done by Wiley etal (60) girls had a higher IGF-1 level than boys 
at birth (p<0.03). Cord blood IGF-1 was associated with sum of skin fold thickness 
positively (p<0.001) apart from most other anthropometric parameters.  
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3. BIRTH WEIGHT, INSULIN AND HOMA-IR IN TERM BORN NEWBORNS: 
 
Sahasrabuddhe etal did a pilot study in India and found that, (61) the insulin and glucose 
levels in full term normal pregnancies was 6.75 ±2.96 mIU/ml and 91.69±27.05 mg/dl 
respectively. 
While lower weight babies had lower glucose and higher insulin values, the heavier 
babies had higher glucose and lower insulin values.  
Hyperinsulinemia, as defined by insulin levels >19 was found in 4 out of 121 babies 
(3.3%).  Three out of the four had low birth weight<2500gms.  
HOMA was greater than 2.5 in 18% of babies and showed a positive correlation with 
hypothyroid mothers. 
The overall incidence of low birth weight was more in complicated pregnancies (31.25%) 
as compared to uncomplicated pregnancies (20%). 
Simental et al, observed in his study that (62). LGA babies showed a strong association 
with hyperinsulinemia (OR 5.02,CI 1.15-22.3 and p=0.01).  
Both LGA and SGA babies exhibited similar HOMA-IR values, however cord blood 
glucose was higher in SGA babies. 
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4. INSULIN/ IGF-1 AXIS AND POST NATAL GROWTH 
 
Dizdarer et al (63),demonstrated that serum glucose levels were  lower in term SGA 
babies  than in term AGA babies,(p<0.05.) and Insulin levels were  higher in term SGA 
infants , than term AGA infants ,( p<0.05). 
Similarly, HOMA-IR values were  higher in term SGA  than in term AGA,( p<0.05) and  
IGF-1 levels were  lower in term SGA  when compared with term AGA infants . 
HOMA-IR values were  higher at 3 and 6 months in well growing SGA children 
compared to both not well growing SGA and AGA children. 
IGF-1 levels were higher at 3 and 6 months in well growing SGA babies compared with 
those not well growing. 
Orbak etal  looked at the association between maternal and fetal serum IGF-1,IGFBP-3 
and leptin levels and early post natal growth in SGA babies.(64). 
It was noted that slower growing SGA babies had lower cord blood IGF-1 values when 
compared to the normally growing ones, concluding that IGF-1 played a role in post natal 
growth.. Also significant positive correlations were found between birth weight and cord 
blood leptin, IGF-1 and IGFBP-3 levels (p<0.001). 
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Ken Ong etal observed that (13) that IGF-1 levels at 5 years were positively correlated to 
weight (p<0.0005) and height (p<0.0005) at 5 years however it was unrelated to the cord 
blood IGF-1 levels. 
It was also found that the IGF-1 levels at 5 years were correlated to the rate of weight 
gain between 0-2 years (p<0.0005) with higher levels in children showing post natal 
catch up growth. 
 
5. CHANGES IN INSULIN SENSITIVITY IN EARLY POST NATAL LIFE AND 
ITS ASSOCIATION WITH CATCH UP GROWTH: 
 
Tong-yan Han etal from China looked at the association between catch up growth and 
insulin sensitivity of SGA born babies at 3 months of life.(65).and  found that SGA 
babies had higher fasting insulin and HOMA-IR levels suggestive of insulin resistance. 
Mericq etal did  a study  to look at changes in insulin sensitivity in small and appropriate 
for gestational age infants from birth to three years(66). 
SGA infants had lower insulin levels than AGA infants (p 0.03) at 48 hours of life. 
However by three years of age the fasting insulin levels were higher in the SGA group,( 
p=0.005). 
SGA infants also had a higher HOMA-IR at 3 years of age compared to AGA infants. 
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At 3 years of age, the rate of weight gain was the most important factor determining 
fasting insulin levels( r=0.47,p=0.003),indicating development of insulin resistance. 
In this context, Iniguez et al  observed that  , SGA infants had lower IGF-1 levels at birth 
which quickly rose till 3 years of age, when levels became higher than that of AGA 
infants. 
 IGF-1 levels at 1 year were associated with gain in length (p=0.049), in contrast IGF-1 
levels at 3 years was associated with weight gain. 
Associations between insulin resistance and low birth weight  was studied by Nestor Soto 
et al.(21). He observed that  SGA infants were shorter, lighter and had a smaller head 
circumference at birth when compared to AGA infants. 
While at 48 hours the fasting glucose levels of SGA and AGA infants was comparable , 
the fasting insulin levels were  lower in the SGA group<0.01. 
Furthermore,fasting insulin levels were  higher in SGA infants with WCUG when 
compared to SGA without WCUG and AGA. 
It was seen that increase in length in the 1
st
 year of life was the only independent factor 
affecting post load insulin secretion at 1 year.(p<0.01). 
Ibanez and coworkers to demonstrated the association of catch up weight gain on early 
onset adiposity and insulin resistance in SGA children..(20). 
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SGA infants gained weight faster than the AGA counterparts between 2 and 4 years of 
age. Between 2 and 4 years of age, the increase in body fat and adiposity were higher in 
SGA children.It was also seen that the lean body weight was lower in SGA children. 
At 2 years of age, SGA children had lower insulin levels and HOMA ,however between 
2-4 years, although the mean IGF-1 levels were similar between both the groups, fasting 
insulin levels increased in the SGA group. 
Milovanovic et al, observed that (22).SGA babies had a lower ponderal index(24.8±1.8 
vs 26.3±3.1) and were thinner than AGA babies.  
At 4 years of age,  SGA children were lighter than AGA children. Also plasma glucose 2 
hours after oral glucose load was higher in SGA when compared to the AGA counterparts 
( p=0.006). 
Insulinogenic index, as calculated by (insulin 30- insulin 0)/(glucose 30- glucose 0) was 
lower in the SGA children ( p=0.02). 
There was symmetrical catch up in weight and height which was independent of the post 
natal feeding practices. 
It was also found that SGA children had a lower glucose stimulated insulin secretion at 4 
years of age when compared to the AGA children. 
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INTRODUCTION : 
This section details the Materials and Methods used in this study.  The study was 
approved by the Institutional Review Board and Ethics committee (IRB min no 9088 
dated 6.10.2014). Informed written consent was obtained from the mothers of all the 
participants at recruitment into the study. 
STUDY SETTING:  
The recruitment and  collection of data at birth  were done in the labour room, neonatal 
intensive care unit and  post natal wards of the Christian Medical College  Vellore. 
Follow-up of this cohort at 3.5 months and 6 months was done in the Paediatric 
endocrinology outpatient clinic of the institution. All recruitment was done by the 
primary investigator of the study.  
 
SAMPLE SIZE CALCULATION: 
In a similar study published earlier (63), the mean difference in IGF-1 levels at birth 
between AGA and SGA babies was 28.5%, standard deviation in AGA group was 28.42 
and that in the SGA was 22.40.  Using   an Alpha error of 1% and Power of  90%,  24 
neonates would need to be recruited in each arm. Considering a dropout  rate of  10% , 
this would equate to 27neonates in each arm. We recruited 60 neonates,  30 each in  the 
SGA and AGA arms of  this study. 
41 
 
STUDY POPULATION: 
All babies born at term between 37-42 weeks of gestation in CMC hospital during the 
study period were eligible for the study. Subjects were excluded if they had :  
1. Birth asphyxia 
2. Mothers with intrauterine infections 
3. Major systemic illness 
4. Major congenital anomalies 
5. Chromosomal anomalies or genetic syndromes 
 
STUDY PERIOD: 
Recruitment for the study commenced in December 2014. The major recruitment 
occurred between December  2014 and February 2015 This was planned with a view to 
enable follow-up of these infants till 6 months of age. To achieve target sample size, few 
subjects were recruited in August 2015 also.  
METHODOLOGY: 
MATERNAL DETAILS AT BIRTH: 
Maternal pregnancy details were collected from the mother‟s hospital records in the 
labour room and postnatal wards. Maternal age, parity, gestational age at delivery and 
mode of delivery were  noted. Maternal risk factors like pregnancy induced 
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hypertension (PIH), gestational diabetes (GDM), and thyroid disorders if present were 
documented. 
Although   maternal height and weight at the first visit to the hospital  were available, 
this information could not be used to calculate the maternal BMI because of non-
uniformity of the data.  As it is common local custom to have antenatal care elsewhere 
and have delivery at another hospital, the first visit to our hospital ranged  from 8 weeks 
of pregnancy  to the time of delivery.   
NEONATAL DETAILS AT BIRTH: 
Physical examination of the neonate was done by the primary investigator to confirm 
term gestation and to rule out major systemic illness, congenital anomalies, 
chromosomal or genetic syndromes. Anthropometry included  weight, length and head 
circumference for all babies  recorded within 24 hours after birth by the primary 
investigator. Weight was measured using an electronic infant  scale with a precision of 
10 gms(Global weighing system Essae DS-252).   Recumbent length was measured 
using an infantometer .Occipitofrontal head circumference was measured using a 
flexible measuring tape. Using weight and length measurements , ponderal index was 
calculated  using the formula (weight in grams/length in cm³)x 100. Subjects were 
followed up in the NICU/postnatal wards till they were discharged from the hospital.  
Cord blood samples were collected  for insulin, glucose and IGF-1 assays in appropriate 
tubes and were sent to the laboratory immediately. The samples had unique code 
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numbers. Glucose samples were analysed immediately, Insulin and IGF-1 samples were 
centrifuged and sera were frozen at -20°C till analysis. Using glucose and insulin 
values, HOMA-IR was calculated using the formula : fasting insulin (µU/ml)x fasting 
glucose (mmol/L)/22.5 
All mothers were advised to give exclusive breast feeds till 6 months of age. Contact 
details of the family were collected and they were advised to return for follow-up at 3.5 
and 6 months as per the study protocol . 
AT 3.5 MONTHS FOLLOW UP:  
All subjects had their weight, length and head circumference measured by the primary 
investigator as described earlier. . Body mass index( BMI)  was calculated using the 
formula weight in kg/height in m². 
Details of the infant‟s diet as well as any significant illness during this period were 
documented. In addition a brief developmental assessment of the infant was done by the 
primary investigator.  
Catch up growth was calculated for all babies in terms of gm/kg/day and  cm/month  for 
gains in weight, length and  head circumference respectively. Weight gain was 
calculated from the 11
th
 postnatal day for all babies. . Differences in the catch up 
growth between AGA and SGA infants was calculated and recorded. Catch-up growth 
was then correlated with the insulin/ IGF-1 at birth.  
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Nelson Textbook of Paediatrics describes the weight, length and gain in head 
circumference during  normal growth in children(19) .  Based on these 
recommendations,   our subjects were arbitrarily  classified into 3 categories: 
a. Inadequately growing: weight gain <20gms/day, length increase of < 
3.5cm/month and increase in head circumference of <2cm/month. 
b. Adequately growing: weight gain 20-30gms/day, length increase of 
3.5cm/month and increase in head circumference of 2cm/month. 
c. Rapidly growing: weight gain >30gms/day, length increase of > 3.5cm/month and 
increase in head circumference of >2cm/month.  
 
The correlation between these 3 categories of growth and their hormonal parameters at 
birth was investigated. 
DETAILS AT 6 MONTHS FOLLOW UP: 
At 6 months of age, details of the infant‟s diet as well as any significant illness during 
this period were documented. In addition a brief developmental assessment of the infant 
was done by the primary investigator. Anthropometric measurements like weight, 
length and head circumference were noted . Fasting (4 hours post feed) blood samples 
was collected for S.insulin, IGF-1 and glucose assays only in SGA babies. However 
due to limitation of time, the 6 months follow up study  could not be completed  and 
follow up will continue after submission.  
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HORMONE ASSAYS 
Cord blood glucose was measured by the hexokinase test  using the COBAS 8000 
analyser. 
S. Insulin and IGF-1 levels  were as measured by chemiluminiscence assay using  
SIEMENS IMMULITE 2000 XPi. The coefficient of variance was 7 for both insulin 
and IGF-1. 
DATA ENTRY AND ANALYSIS: 
Data was prospectively entered in Epidata software version 3.1 and analysis was done 
using SPSS version 21.. 
Student‟s t test was used for comparison of means whereas Mann whitney U test was 
used for comparison of differences between the SGA and AGA groups. 
1. Neonatal parameters including gestational age,   anthropometric measurements and  
ponderal index were compared between the groups. . 
2. The effect of maternal age, parity and risk factors ( gestational diabetes and 
hypertension) on birth weight was noted. 
3. The mean insulin and IGF-1 levels were calculated at birth for both SGA and AGA 
babies and the difference was analysed using the Mann-Whitney U test. 
4. For those available, HOMA-IR was compared between the two groups. 
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5. Linear regression was done with insulin and IGF-1 levels across all  gestational ages 
and birth weights. 
6. Anthropometric variations at 3.5 months between AGA and SGA were recorded and 
differences in catch up growth was noted between the 2 groups. 
7. Subjects were divided into adequately growing, inadequately growing and rapidly 
growing based on catch up growth and differences in SGA and AGA groups noted. 
8. The catch-up growth at 3.5 and 6 months was correlated with the hormonal 
parameters at birth. 
9. Comparison of our data with data from  other studies was done  using unpaired t test. 
10. Results were expressed as median ±SDS. P value was considered significant if  
 < 0.05. 
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                       RESULTS 
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This section is divided into three subgroups: 
1. Results of the baseline parameters at birth 
2. Results of the follow-up study at 3.5 months 
3. Results of the follow-up study at 6  months 
1. Results of the baseline parameters at birth 
Baseline characteristics 
There were 30 subjects in the SGA group and 30 in the AGA  group. All except one set 
of SGA  twins were born singleton. Excluding them did not affect the statistical analysis, 
therefore they were included in the analysis. Similarly there were 3 babies who were 
large for gestational age In view of their very small number they were also included in 
the analysis. 
 
 
The baseline characteristics of the cohort are shown below in Table 1. 
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TABLE 1: BASELINE CHARACTERISTICS 
 N MEAN SD P value 
BIRTHWEIGHT(gms)     
SGA 30 2031.667 209.9767 <0.01 
AGA 30 3188 478.627  
     
LENGTH(cm)     
SGA 30 44.96667 2.092406 <0.01 
AGA 30 49.23333 2.062528  
     
HEAD 
CIRCUMFERENCE(cm) 
    
SGA 30 31.33667 1.119262 <0.01 
AGA 30 33.98 1.07  
     
GESTATIONAL 
AGE(wks) 
    
SGA 30 38.03667 0.937158 <0.01 
AGA 30 39.31667 1.004845  
     
PONDERAL INDEX     
SGA 30 2.236333 0.239878 <0.01 
AGA 30 2.658 0.286265  
 
 
As expected, SGA babies were lighter, shorter and had smaller head circumference as 
compared to the AGA group.  In addition they had lower Ponderal index as compared to 
the AGA group. Interestingly, although all the infants were born at term, there was a 
difference between the gestational ages between the groups with the  SGA group being 
born earlier.  
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TABLE 2: GENDER WISE DISTRIBUTION OF THE COHORT IS SHOWN 
BELOW IN TABLE 2. 
 
 
AGA/SGA MALES FEMALES P value 
SGA 15 (50%) 15(50%)  
AGA 13(43.33%) 17(56.67%) 0.605 
TOTAL 28(46.67%) 32(53.33%)  
 
 
 
There were no differences in the number of males and females either in the SGA or AGA 
group. 
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FIGURE 3.1:GENDER WISE DISTRIBUTION OF 
SGA INFANTS 
Males
Females
FIGURE 3.2:GENDER WISE DISTRIBUTION OF 
AGA INFANTS 
males
females
N=15(50%
) 
N=15(50%) 
N=13(43.3%) 
N=17(56.6%) 
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THE CORD BLOOD LEVELS OF INSULIN AND IGF-1 IS SHOWN BELOW IN 
TABLE 3. 
 
VARIABLE SGA AGA  SGA AGA 
CORD 
INSULIN(µU/ml) 
  CORD  
IGF-
1(ng/ml) 
  
N 30 30  30 30 
MEDIAN 2 2.45  25 43.4 
MIN 2 2  25 25 
MAX 6.55 34.7  47 156 
P-VALUE                 0.002  <0.01 
 
 
Cord blood insulin & IGF-1 levels were significantly lower in the SGA  group as 
compared to the AGA group.  
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Because of inadequate sampling and delay in reaching the laboratory, cord blood glucose 
values were available only for 21 babies .Therefore HOMA-IR could be calculated only 
for 21 babies and is shown below in Table 4. 
Table 4.Cord blood Glucose & Insulin levels /HOMA-IR 
 
 
PARAMETER SGA(N=5) AGA(N=16) P VALUE 
GLUCOSE(mg/dl) 74 94.625  
INSULIN(µU/ml) 3.028 8.225  
HOMA-IR 0.616(±0.457) 1.9675(±2.0727) 0.17 
. 
 
HOMA-IR appeared to be higher in the AGA babies although  there was no statistical 
difference . 
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There was no gender wise difference in the cord blood insulin and IGF-1 levels within 
the SGA and AGA group of subjects This is shown below in Table 5.The AGA boys 
were heavier, longer and had a larger head circumference compared to the AGA girls. 
Whereas in the SGA group, the boys tended to be longer with a larger head 
circumference. 
TABLE 5.: GENDER WISE DIFFERENCE BETWEEN THE SGA AND AGA 
INFANTS FOR CORD BLOOD INSULIN AND IGF-1. 
 
 
                        SGA                     AGA 
 Males Females  P Males Females P 
WEIGHT(gms) 2054.667 2008.667 0.558 3473.08 2970.00 0.002 
LENGTH(cm) 45.667 44.2667 0.066 50.38 48.35 0.004 
HEAD 
CIRCUMFERENCE 
(cm) 
31.7867 30.8867 0.026 34.46 33.62 0.022 
INSULIN(µU/ml) 2 2 0.39 3.07 2.34 0.62 
IGF-1(ng/ml) 25 25 0.52 50.96 47.53 0.75 
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TABLE 6: COMPARISON BETWEEN BASELINE NEONATAL 
CHARACTERISTICS OF TERM AGA BABIES IN OUR STUDY WITH OTHER 
INDIAN STUDIES. 
 
 Our  Study S.MITRA etal, 
Puducherry(59) 
  
 MALES 
(n=13) 
FEMALE
S 
(n=17) 
MALES 
(n=26) 
FEMALES 
(n=24) 
Pm Pf 
Weight(gms) 3473.08± 
371.89 
 
2970± 
441.54 
3080± 
540 
 
2920± 
380 
0.024
1 
0.70 
Length(cms) 50.38±1.55 
 
 
48.35±1.99 48±2 
 
47±1 0.000
6 
0.006
7 
Head 
Circumferen
ce 
(cms) 
34.46±0.74
9 
 
33.62±1.15
3 
34.09±1.73 
 
33.23±1.57 0.46 0.38 
Insulin(µU/m
l) 
5.33±6.15 5.69±8.2 15.15±15.93 11.77±10.95 0.039
6 
0.060
3 
Pm- p value is for comparison of males between the 2 studies. 
Pf- p value is for comparison of females between the 2 studies. 
The table shows that there was a significant difference among the birth weight of boys 
between the 2 studies. The length was also significantly different among both the sexes. 
In the  term AGA group, Vellore boys were heavier and longer than the ones from 
Puducherry, and our girls were longer than the Puducherry girls. 
Despite being lighter and shorter the boys in the Puducherry cohort had higher insulin 
levels. , girls showed a trend towards higher insulin levels.  
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TABLE 7: COMPARISON BETWEEN BASELINE NEONATAL 
CHARACTERISTICS OF TERM BABIES IN OUR STUDY WITH 
INTERNATIONAL STUDIES. 
OUR 
STUDY 
 Weight 
(gms) 
Length 
(cms) 
Insulin 
(µU/ml) 
IGF-1 
(ng/ml) 
AGA (n=13) M 3473.08±371 50.38±1.55 5.33±6.15 50.97±35.66 
          (n=17) F 2970±441 48.35±1.99 5.69±8.2 47.53±24.13 
SGA (n=15) M 2054.66±232 45.66±1.95 2.59±1.25 28.06±7.13 
         (n=15) F 2008.66±190 44.26±2.05 2.28±0.54 28.46±13.98 
DIZDARER 
et al(63) 
     
AGA (n=10) M 3568±347.87 51.2±3.45 6.835±3.98 69.07±28.42 
          (n=5) F 3230±543.98 50.3±3.4   
SGA  (n=8) M 2167±790.90 46.25±4.41 7.445±4.47 40.52±22.4 
          (n=15) F 1972±567.70 45.53±3.36   
P1-AGA M 0.5391 0.4521   
 F 0.2830 0.1172   
SGA M 0.6067 0.6582   
 F 0.8173 0.2218   
IBANEZ 
et al(58) 
     
AGA (n=24) M 3400  5.6±0.9 64±6 
          (n=24) F 3400  9.4±1.1 84±5 
SGA (n=24) M 2300  3.3±0.6 41±4 
         (n=24) F 2300  6.3±0.8 59±5 
P2-AGA M   0.8323 0.0863 
 F   0.0338 0.0001 
     SGA M   0.0221 0.0001 
 F   0.0001 0.0001 
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P1- p value is for gender wise comparison of weight and height between Indian babies 
and those from Turkey (Dizdarer). 
P2- p value is for gender wise comparison of insulin and IGF-1 levels between Indian and 
Spanish babies (Ibanez). 
The Vellore cohort was similar to the Turkish cohort in anthropometry and hormonal 
parameters.  
The Spanish babies were controlled for birth weight. However, their AGA girls and SGA 
boys and girls had higher insulin and IGF-1 levels compared to our cohort. 
This comparison shows that anthropometric measurements among AGA and SGA babies 
are similar in India,  and Turkey. However gender differences were noted in the study 
done by Ibanez with cord blood insulin and IGF-1 being higher in girls than in boys. 
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FIGURE 5:THE CORRELATION BETWEEN MATERNAL AGE AND BIRTH 
WEIGHT IS SHOWN IN FIGURE 1 BELOW. 
 
 
 
 
 
 Low birth weight babies ( babies weighing < 2500 gms)  are scattered across all the 
maternal ages (20-35  years).  Athough not significant, there was a trend  
(p=0.59) towards increasing birth weight ( weighing> 3500gms) with increase in 
maternal age > 25 years. 
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Eleven of the 59 mothers had gestational diabetes. All of them were on diet control and 
none were receiving medication for diabetes. Shown below in Table 8 is the correlation 
between maternal gestational diabetes (GDM) and the birth parameters.  
Maternal GDM and Offspring birth weight  
GESTATIONAL 
DIABETES 
N MEAN 
BIRTHWEIGHT(gms) 
SD P value 
YES 11 2660 943.9041 0.79 
NO 48 2598.571 629.7354  
 
Maternal GDM and Offspring cord blood insulin level 
GESTATIONAL 
DIABETES 
N MEDIAN 
(INSULIN)µU/ml 
MIN-MAX P-VALUE 
YES 11 2 2-6 0.61 
NO 48 2 2-34  
 
Maternal GDM and Offspring cord blood IGF-1 level 
GESTATIONAL 
DIABETES 
N MEDIAN 
(IGF-1)ng/ml 
MIN-MAX P VALUE 
YES 11 25 25-80 0.89 
NO 48 27 25-156  
 
Table 8 shows that maternal gestational diabetes did not have a significant impact on the 
offspring‟s  birth weight and cord blood insulin or IGF-1 levels. 
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Although the sample size of mothers with GDM were limited, there was no difference in 
their offspring‟s  SGA and AGA outcome as shown below in Table 9. 
 
 
TABLE 9:  SGA/AGA BIRTH IN RELATION TO MATERNAL DIABETES 
MELLITUS. 
 
 
GESTATIONAL 
DIABETES 
SGA AGA TOTAL 
YES 6 (54.55%) 5 (45.45%) 11 
NO 24 (48.98%) 25 (51.02%) 48 
TOTAL 30 30  
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The impact of gestational age on cord blood insulin across  37-42 weeks of gestation was 
studied and is shown in Figure 6 below. 
 
FIGURE 6: CORRELATION BETWEEN GESTATIONAL AGE AND CORD 
BLOOD INSULIN. 
 
 
This graph shows that there was no correlation between gestational age and cord blood 
insulin levels. (p=0.12). 
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The impact of birth weight on cord blood insulin was studied and is shown below in 
Figure 7. 
FIGURE 7: CORRELATION BETWEEN BIRTH WEIGHT AND CORD BLOOD 
INSULIN. 
 
 
 
As shown in the graph above, there was a linear correlation between birth weight and 
cord blood insulin  levels (p=0.01). Across the birth weights, there was increase in cord 
blood insulin leves. With increase in birth weight, the insulin levels tended to increase. 
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Likewise, the impact of  gestational age and birth weight on cord blood IGF-1 level was 
also studied. 
Shown in Figure 8 below is the correlation between gestational age and cord blood IGF-1 
level . 
FIGURE 8: CORRELATION BETWEEN GESTATIONAL AGE AND CORD 
BLOOD IGF-1. 
 
 
 
There was no correlation between gestational age and cord blood IGF-1 levels. 
(p=0.41). 
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The correlation between birth weight  and cord blood IGF-1 level is shown below in 
Figure 9. 
 
FIGURE 9: CORRELATION BETWEEN BIRTH WEIGHT AND IGF-1 LEVELS 
 
 
 
 
 
There was a strong positive correlation between birth weight and IGF-1 levels. 
(p<0.01) across all birth weights. 
0
.0
0
5
0
.0
0
1
0
0
.0
0
1
5
0
.0
0
c
o
rd
 b
lo
o
d
 I
G
F
1
1500 2000 2500 3000 3500 4000
at birth weight
Ng/ml 
grams 
65 
 
We also investigated the correlation between ponderal index at birth and the cord blood 
hormonal parameters and this is shown in Table 10 below. 
 
TABLE 10: CORRELATION BETWEEN PONDERAL INDEX AND CORD 
BLOOD INSULIN AND IGF-1. 
 
 
 PONDERAL INDEX P-VALUE 
CORD BLOOD INSULIN 0.2 0.11 
CORD BLOOD IGF-1 0.59 <0.01 
 
 
As is shown above, there was strong correlation between ponderal index and cord blood  
IGF- at birth. However there was no such correlation between ponderal index and cord 
blood insulin level. 
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RESULTS OF THE FOLLOW UP STUDY AT 3.5 MONTHS. 
 
50 of the 60 infants of the initial cohort  had completed 3.5 months of age and were 
eligible to be included in the Follow-up study. Thirty five of them ( 22 SGA, 13 AGA) 
returned for follow-up and were included in the study. The anthropometric indices of this 
cohort are shown below in Table 11.  
 
TABLE 11: ANTHROPOMETRIC INDICES AT 3.5 MONTHS  
WEIGHT(gms) N MEAN SD P-VALUE 
SGA 22 4475.909 621.7691 <0.01 
AGA 13 5930.769 933.3404  
LENGTH(cm)     
SGA 22 56.13636 2.932502 <0.01 
AGA 13 60.76923 2.74329  
BMI     
SGA 22 14.12727 1.33316 0.004 
AGA 13 15.90769 2.132472  
HEAD 
CIRCUMFERENCE 
    
SGA 22 37.34 1.3486 <0.01 
AGA 13 39.38 1.0636  
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As shown in the Table above, at 3.5 months, the SGA babies continued to be lighter, 
shorter, had smaller head circumference as well as lesser BMI as compared to their AGA 
peers. . 
The follow-up cohort was investigated for any difference in anthropometry  based on 
their gender. This is shown in Table 12 below. 
TABLE 12: GENDER WISE DIFFERENCE IN ANTHROPOMETRY AT 3.5 
MONTHS. 
WEIGHT(gms) N MEAN SD P-VALUE 
MALES 16 5086.25 871.9853 0.71 
FEMALES 19 4957.368 1162.329  
LENGTH(cms)     
MALES 16 58.375 3.138471 0.44 
FEMALES 19 57.42105 4.018233  
HEAD 
CIRCUMFERENCE(cms) 
    
MALES 16 38.40625 1.66552 <0.01 
FEMALES 19 37.84211 1.518887  
BMI     
MALES 16 14.84375 1.60581 0.87 
FEMALES 19 14.74211 2.095316  
 
 Boys had larger head circumference as compared to the girls at 3.5 months. In all other 
parameters they were similar.  
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Shown below in Table 13 is the comparison of the catch-up growth between the SGA and 
AGA cohort. 
TABLE 13: CATCH UP GROWTH IN SGA/AGA BABIES AT 3.5 MONTHS. 
 
WEIGHT(gms/day) N MEAN SD P-VALUE 
SGA 22 25.42455 0.299357 0.18 
AGA 13 28.93546 0.226427  
LENGTH(cm/month)     
SGA 
 
22 3.270455 0.493447 0.94 
AGA 13 3.282308 0.448407  
HEAD 
CIRCUMFERENCE(cm/month) 
    
SGA 22 1.716364 0.299357 0.05 
AGA 13 1.527692 0.226427  
 
 
This table shows that SGA and AGA babies had similar growth rates in terms of weight 
and length at 3.5 months of age.  
However there was a trend towards larger  head circumference in   SGA babies as  
compared to AGA babies. 
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TABLE 14: CATCH UP GROWTH IN AGA/SGA BABIES 
 
 ADEQUATELY 
GROWING 
INADEQUATELY 
GROWING 
RAPIDLY 
GROWING 
WEIGHT    
SGA(n=22) 13(59.1%) 5(22.7%) 4(18.2%) 
AGA(n=13) 4(30.8%) 3(23.1%) 6(46.2%) 
LENGTH    
SGA(n=22) 7(31.8%) 9(40.9%) 6(27.3%) 
AGA(n=13) 2(15.4%) 7(53.8%) 4(30.8%) 
 
 
At 3.5 months, 59.1% of the SGA babies were adequately growing while 46.2% of AGA 
babies were rapidly growing in terms of increase in weight. 
Majority of the babies were inadequately growing in terms of length at 3.5 months. 
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FIGURE 10.1:WEIGHT CATCH UP IN SGA/AGA 
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FIGURE 10.2:LENGTH CATCH UP IN SGA/AGA 
INFANTS 
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We looked at the effect of cord blood insulin level on the infants‟ catch-up growth at 3.5 
months  in terms of weight & length as is shown below in Figure 11 & 12 respectively. 
 
FIGURE 11: CORRELATION BETWEEN CORD BLOOD INSULIN AND 
WEIGHT GAIN AT 3.5 MONTHS. 
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FIGURE 12: CORRELATION BETWEEN CORD BLOOD INSULIN AND 
LENGTH GAIN AT 3.5 MONTHS. 
 
 
 
 
 
As shown in the Figures above, there was no  correlation between cord blood insulin 
levels and weight gain.(p= 0.95) as well as length gain (p=0.48) at 3.5 months of age.  
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Similarly we also looked at the effect of cord blood IGF-1 level and catch-up growth at 
3.5 months as shown below in Figure 13&14 respectively. 
 
FIGURE 13: CORRELATION BETWEEN CORD BLOOD IGF-1 AND WEIGHT 
GAIN AT 3.5 MONTHS. 
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FIGURE 14: CORRELATION BETWEEN CORD BLOOD IGF-1 LEVELS AND 
LENGTH GAIN AT 3.5 MONTHS. 
 
 
 
 
As shown in the Figures above, cord blood IGF-1 did not impact growth at 3.5 months of 
age either in terms of weight (p=0.37) or length gain(p=0.98). 
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RESULTS OF THE FOLLOW UP STUDY AT 6 MONTHS OF AGE 
Of the 60 babies in the initial cohort, only 41 babies had completed 6 months of age and 
were eligible for the 6 months follow-up study. Of these, only 5 babies (4 SGA) returned 
for follow-up. Because of the limited sample size, the characteristics of each of these 
subjects are individually described. No statistical analysis was done between the groups. 
TABLE 15: ANTHROPOMETRIC INDICES AT 6 MONTHS OF AGE. 
 
PARAMETER BABY 1 BABY 2 BABY 3 BABY 4 BABY 5 
AGA/SGA SGA SGA SGA SGA AGA 
GENDER boy girl boy girl Boy 
AT BIRTH  
WEIGHT(gms) 2220 2240 2250 
 
2150 3900 
LENGTH(cms) 48 46 49 45 50 
HC(cms) 30 31 32 32 36 
3.5MONTHS  
WEIGHT(gms) 
Catch 
up(g/day) 
4500 
24 
4480 
23.5 
5400 
33.1 
4050 
20 
5040 
12 
LENGTH(cms) 
Catch 
up(cm/mon) 
60 
3.4 
 
59 
3.7 
58 
2.5 
55 
2.85 
60 
3.1 
HC (cms) 
Catch 
up(cm/mon) 
37 
2 
37 
2 
40 
2.28 
38 
1.7 
39 
1 
6 MONTHS  
WEIGHT(gms) 
Catch 
up(g/day) 
6680 
29.06 
6040 
20.8 
6760 
18 
5960 
25.46 
6920 
25.06 
LENGTH(cms) 
Catch 
66 
2.4 
66 
2.8 
61 
1.2 
64 
3.6 
66 
2.4 
76 
 
up(cm/mon) 
HC(cms) 
Catch up 
(cm/mon) 
41 
1.6 
39 
0.8 
41.5 
0.6 
41 
1.2 
41.5 
1 
 
 
During the first 3.5 months, in the SGA group, 3 babies showed adequate catch-up (20-30 
gm/day) while one of them showed rapid catch-up. The LGA baby showed catch-down 
growth with a mean gain of only 12 gm/day.   
All had inadequate growth in terms of length and head circumference at 3.5 month. 
However at 6 months all except 1 SGA baby had rapid weight catch up(>20 gms/day). 
The same baby showed inadequate gain in length and head circumference also. 
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Hormonal assay was also done during the 6 month Follow-up and results are shown in 
Table 16 below. 
TABLE 16: HORMONAL PARAMETERS AT 6 MONTHS OF AGE: 
 
PARAMETER BABY 1 BABY 2 BABY 3 BABY 4 BABY 5 
SGA/AGA SGA SGA SGA SGA AGA 
SEX BOY GIRL BOY GIRL BOY 
AT BIRTH      
INSULIN 2 2 2 2 2.32 
IGF-1 25 29.2 28.7 25 156 
AT 6 
MONTHS 
     
GLUCOSE 76 90 95 71 86 
INSULIN 3.05 2 3.65 2 2.812 
IGF-1 38.4 67.2 32.1 78 25 
 
Although the LGA baby had very high IGF-1 level at birth, his length was only 50 cm. At 
6 months he had the lowest level of IGF-1 in the group. His growth parameters showed a 
catch-down growth. 
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                    DISCUSSION 
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In this study we recruited 60 infants , 30  of them born  SGA and 30 born AGA at birth. 
Their anthropometry and birth details along with the maternal details  were recorded and 
cord blood was sampled for glucose, insulin and IGF-1 levels. They were prospectively 
followed up at 3.5 months and their growth velocity as well correlation with the 
hormonal parameters at birth were investigated. Their follow-up at 6 months of age is 
ongoing. There was no difference between the number of boys and girls in each group at 
birth. 
As expected, the SGA cohort were leaner, shorter and had smaller head circumference 
than the AGA group (Table 1). We compared the neonatal anthropometry of our infants 
with other available Indian data. . Only data for term AGA babies were available for 
comparison. In comparison with the Puducherry cohort, our boys  were heavier.  In terms 
of  length, both  boys and girls in our group were longer.  (Table 6, (59)). This difference 
is significant particularly because more than one third of the  Puducherry cohort (8/26) 
were LGA babies as compared to our cohort where only 2 of the 13  babies were LGA.  
In  comparison with the Nagpur  cohort, our babies were heavier at birth(46).. Although 
Puducherry and Vellore( the location of our study cohort) are geographically closely 
located in South India the differences in the neonatal anthropometry between the 2 
cohorts may be due to the difference in the socioeconomic status of the  parents with the 
Vellore cohort being representative of a higher socioeconomic strata. In addition, India is 
a very diverse country where each geographical area has unique cultural and dietary 
practices  in addition to numerous other differences and these may also explain the birth 
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size differences in the various parts of India. .  When compared to the international data 
our cohort was similar to the Turkish cohort in weight and length. (Table 7).   When we 
analysed the neonatal anthropometry between  boys and girls in the SGA and AGA 
groups  , the findings were interesting. In the AGA group, as expected, the girls were 
lighter, shorter and had smaller head circumference than the boys (Table 5). This is the 
usual growth pattern where females are smaller made than males. However in the SGA 
group, the only difference was in the head circumference wherein the girls had smaller 
head circumference than the boys. It is possible that there is an interplay of multiple 
factors namely genetic/ intrauterine environmental and hormonal which result in  fetal 
growth restriction and this occurs irrespective of the gender. On the other hand, it  may  
also be possible that the male fetuses are relatively  more growth retarded  than the 
females such that eventually there is no significant difference in birth size between the 
genders. Several studies in animal and human models including maternal undernutrition 
studies have reported sexual dimorphism with   an accentuation of adverse phenotype in 
males(67),(68),(69),(70).  
The SGA cohort in our study were born earlier as compared to the AGA cohort although 
all were born at term. This may be explained by the fact that in view of SGA status as 
well as the aetiological factors for SGA (for eg.maternal preeclampsia), early termination 
of  pregnancy may have occurred in the SGA group.  
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We then compared  the cord blood hormonal parameters at birth which included  insulin, 
glucose, and IGF-1 levels between our AGA and SGA cohorts. The median insulin level 
in the  AGA group was 2.45 µU/ml when compared to 2 µU/mlin SGA babies (p=0.002).  
This is similar to  various other studies where the cord blood levels of insulin were found 
to be higher in term AGA as compared to SGA babies.(In fact  there was a positive linear 
correlation between birth weight and cord blood insulin  levels (p=0.01)  across the birth 
weights in our study (Figure 7).  
It is well known that  insulin with its anabolic action plays a key role in fetal growth and 
therefore has a positive correlation with the size at birth.  However this is in contrast to 
the findings of Dizdarer et al where the term born SGA group had higher insulin levels at 
birth as compared to the AGA group.(63). 
Simental et al also documented higher insulin level in their SGA cohort, however this did 
not reach statistical significance because of the very small number of SGA babies in their 
cohort(62). Higher insulin levels in the SGA group in these studies may be evidence of 
development of  insulin resistance in utero.  
 
In comparison with other Indian data, the cord blood insulin levels of the AGA babies in 
our study was comparable with those of the Nagpur cohort ( 2,40 ±0.97 vs 6.75±2.96             
respectively) (61). However this was in contrast with data from another similar South 
Indian cohort where the AGA babies had higher insulin levels  as compared to our AGA 
82 
 
cohort (10.96±13.28 vs 2.40 ±0.97mIU/ml respectively( p value=0.0008)(56). This was 
despite the fact that the Puducherry  AGA cohort were lighter as compared to our group. 
While  the higher insulin levels could be related to the ambient glucose levels ( data of 
concurrent glucose levels not available)this may also suggest a degree of insulin 
resistance in them(56). Data on SGA babies is scarce from India, therefore we could not 
compare our SGA cohort with other Indian data.  
HOMA-IR could only be calculated in limited number of subjects in our study because of 
reasons described earlier. HOMA-IR of  our AGA cohort was similar to the Nagpur 
cohort (1.967 vs 1.52 respectively)(30) . There was insufficient data from the SGA group 
for comparison. Dizdarer et al have reported increased HOMA-IR in their SGA group 
when  compared to the AGA group ((63). Similarly, HOMA-IR was higher in the SGA 
cohort  of Simental‟s study although this did not reach statistical significance(62). It is 
absolutely imperative to assess plasma glucose levels as early as possible after collection 
in order to obtain correct result .This should be done to prevent glycolysis and uptake of 
glucose in the sample by the RBS‟s.The glycolysis can also be prevented by using 
fluorinated tubes as the fluoride inhibits glycolysis.. This makes it technically 
challenging. In addition the reliability of cord blood glucose level is questionable as it is 
dependent on factors such as maternal glucose level, stress of delivery etc. Therefore 
although fasting levels of insulin and glucose as well as the calculated value of HOMA-
IR have been widely used as  surrogates for insulin sensitivity in large population studies, 
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these values as described in the Literature review section cannot be used to precisely 
evaluate glucose-insulin axis in vivo.  
IGF-1 is a key hormone regulating fetal growth and it is primarily controlled in utero by 
insulin. As expected our AGA group with greater insulin levels had  higher IGF-1 levels 
as compared to the SGA group(43.4 vs 25µU/ml, p<0.01,Table 3). This is consistent with 
several other epidemiological studies( (32),(63),(71). In fact both birth weight and 
ponderal index showed a strong positive correlation with IGF-1 levels in our study. 
In contrast ,in a meta analysis of 11 observational studies reported by Elhdadad et al, the 
IGF-1 levels in term AGA and SGA babies were comparable(72).In this systematic 
review, the IGF-1 levels were higher in LGA group as compared to the  AGA group 
thereby concluding an association of  IGF-1 and fetal growth only in the higher range of 
the birth weight spectrum.  They also reported higher IGFBP-1 levels in SGA infants and 
suggested a key role of this hormone in the intrauterine growth of SGA infants.  
In the above context, Dizdarer et al‟s findings were quite interesting. In contrast to most 
of the other studies including our study, at birth, the SGA group in their study had lower 
IGF-1 levels despite having higher insulin levels than their AGA group.  The authors 
have suggested insulin resistance and secondary hyperinsulinism playing a role in 
altering the IGF-IGFBP axis in SGA infants.    
Gender specificity in adiposity and its related parameters have been demonstrated in 
some studies. Healthy girls born at term while being lighter have been documented to  
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have more adiposity ,  higher insulin, IGF-1 and leptin levels as compared to boys 
(73),(74),(75). In an elegant study,  Ibanezetal reported similar gender specific findings  
in term born SGA girls((58). Girls born at term, both AGA as well as SGA although had 
similar birth weight as the  boys in their respective group had strikingly  higher  levels of 
insulin and IGF-1, In addition AGA girls in their group had greater fat mass ( measured 
by DEXA scan) as compared to boys although there was no genderwise difference among 
the SGA group.    This was in contrast to our findings wherein AGA girls were although 
lighter at birth than boys, their hormonal parameters were similar. In SGA group there 
was no gender wise difference either in birth weight or in the hormonal parameters.  
 
Postnatal growth at 3.5 months & 6 months of age 
Of the 50 infants who had completed 3.5 months of age by the end of the study period,  
35 infants (22 SGA, 13 AGA) were  followed up and were included in the study. It was 
interesting to note that the postnatal growth velocity was similar in the SGA and AGA 
cohort. We then investigated as to whether there was a difference in weight or length gain 
between the groups. Both in terms of gain in weight (25.43±0.29 vs 28.94±0.23 
gm/kg/day respectively, p=0.18) and in length  (3.27±0.49 vs 3.28±0.44 respectively, 
p=0.94) ,  the SGA and AGA groups were similar(Table 13) . As the SGA group were 
smaller than the AGA group at birth in all the anthropometric measurements and in the 
subsequent months their growth velocity was similar to the AGA group, the SGA group 
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remained lighter, shorter and with lower BMI than the AGA group at 3.5 months of 
age(Table 12). 
Three patterns of growth have been described in the first year of life in children: normal 
growth, catch-up growth and catch down growth,(18),(76).Weight and height growth 
above or below the statistical limits of normal is defined as catch up or catch down 
growth. This phenomenon of catch up allows the growth restricted babies to reach growth 
which is similar to healthy babies born at term. When we analysed the growth of our 
cohort as described in the section on Methodology,  approximately half  of the AGA 
group exceeded the expected weight gain as opposed to less than a quarter of the SGA 
group( Table 14). Close to a quarter from each group had inadequate weight gain and the 
remaining were growing in the expected normal range. Surprisingly approximately half 
of the cohort from each group did not show adequate gain in length. In Soto et al‟s cohort 
of  term SGA and AGA infants, 73% of the SGA group showed weight catch-up but only 
52% showed length catch-up by 1 year of age(21).. Interestingly neither the cord blood 
levels of insulin/ IGF-1 had any effect on either gain in weight or length at at 3.5 months 
of age in our study.  
Rapid postnatal weight gain is known to be associated with adverse hormonal milieu as 
early as infancy. Dizdarer et al had reported higher insulin and HOMA-IR values in 
well growing SGA infants at 3 & 6 months of age as compared to the SGA group who 
did not grow well(63).  There were no similar findings in the AGA group even in those 
who had shown accelerated weight gain. The authors therefore concluded that postnatal 
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catch-up growth may adversely affect the glucose metabolism in those born SGA in 
their later life. Similar findings were also reported by Soto et al(77). At 1 year of age 
their SGA group who showed weight catch-up, developed higher fasting insulin levels 
although they were not overweight.  Therefore although it is comforting to note that our 
SGA cohort, even those who showed  adequate postnatal growth, remained smaller at 
3.5 months of age, it is important to follow them up longitudinally and assess for early 
development of insulin resistance. There are no definite recommendations available as 
to how much and how fast the SGA babies need to grow to remain metabolically 
healthy. 
After early infancy, IGF-1 is mostly influenced by growth hormone. In Dizdarer‟s 
study.the well growing SGA group had higher IGF-1 levels at 3 & 6 months of age 
although on an average the SGA group had lower IGF-1 levels at birth. Similar findings 
were also reported by Soto et al(21). We did not have sufficient data at 6 months for 
comparison. Dizdarer eta l speculated that due to the development of early insulin 
resistance which alters the IGF-IGFBP axis,  SGA babies who grow well during infancy 
have a tendency for decelerated growth in later life and eventually become short adults 
without reaching  their genetic height potential. Currently growth hormone therapy is 
recommended for children born SGA with poor height velocity to improve their final 
height outcome.   
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Reduced insulin sensitivity is a well established early metabolic abnormality in the 
pathogenesis of adult onset diseases including type 2 diabetes mellitus mellitus, 
hypertension and Atherosclerosis(35),(78),(79).   
The most important environmental factor adversely affecting insulin sensitivity is  
obesity, in particular abdominal adiposity. s(80),(81),(82). Therefore prevention of 
obesity remains one of the most important modifiable factors affecting insulin resistance. 
Catch-up growth in SGA infants is mostly complete by 2-3 years of age. Infancy, in 
particular, the first 6 months is the period of maximum growth after birth. Rapid growth 
during infancy has been associated with obesity in later life.. Those with insulin 
resistance may remain asymptomatic for several years and in later years they may or may 
not develop diseases linked with metabolic syndrome. This gives a  long window period 
during which interventions such as lifestyle modifications (healthy diet, regular physical 
exercise) will reduce the impact of insulin resistance.  
 
Our cohort, both the AGA and SGA groups did not demonstrate insulin resistance in 
terms of hyperinsulinaemia at birth. In addition. on an exclusive breast feed diet, close to 
60% of the SGA cohort demonstrated postnatal growth in the “adequate” range. Despite 
adequate growth the SGA group remained smaller than the AGA group at 3.5 months of 
age. Current evidence suggests that remaining relatively smaller may benefit them from 
the risk of developing insulin resistance and metabolic syndrome in later life. However 
the accelerated weight gain in almost half of the AGA infants is worrying. As insulin 
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resistance is augmented by obesity it is important that their growth is  monitored long 
term and rapid catch-up weight gain is avoided. 
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                     LIMITATIONS 
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This study has several limitations. One important limitation was the limited sample 
size during follow-up, particularly at 6 months of age. Correlation of 
anthropometry and hormonal parameters with the catch-up growth at 6 months 
would have given us valuable information. Another limitation was insufficient 
glucose sampling at birth thereby limiting assessment of HOMA-IR. In addition  
we did not have  the maternal pre-pregnancy weight  and subsequent BMI for 
correlation with the birth size.   
 
  
 
 
 
 
 
 
 
 
 
 
 
91 
 
 
 
 
 
 
                  CONCLUSIONS 
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1. Insulin and IGF-1 were lower in term born SGA babies in comparison   with  
AGA babies. 
2. There was a linear positive correlation between the birth weight and the cord 
blood insulin and IGF-1 levels across all term gestational ages. 
3. With  exclusive breast feeding, there was no difference in catch up growth in 
terms of both weight and length between the  SGA and AGA groups at 3.5 months 
of age, However SGA babies continued to be lighter and shorter than AGA babies 
at 3.5 months.  
4. Long term follow-up of this cohort will give more insight into when, if at all, the 
SGA subjects catch-up with their peer group in terms of growth. In addition 
whether this group will develop an adverse metabolic milieu with rapid catch-up 
growth remains to be seen.. 
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INFORMED CONSENT  
Christian Medical College, Vellore 
                                                      Department of Child health-Unit-1 
 
Study title: Correlation between cord blood insulin/IGF-1 and early postnatal 
growth in small for gestational age babies. 
INFORMATION SHEET 
You are being requested to take part in this study to see if babies born small for 
gestational age have lower insulin and IGF-1 level at birth and whether the levels 
increase with post natal growth leading to insulin resistance and long term health 
risks. 
Why are we doing this study? 
It has been observed that babies born small ( low birth weight) have an increased 
risk of developing diseases like diabetes, hypertension, heart disease etc when 
they are adults.  This risk is more if the babies who are born small grow rapidly  
after birth. Food intake is one of the most important factors affecting the growth 
of children. In addition there are certain hormones which affect the growth of 
children before and after birth. In babies who are born small, the hormone levels 
may be different at and after birth from those who are born with normal birth 
weight.  These hormones as well as the baby’s food intake affect the growth in 
children particularly those who are born small. In this study we plan to look at 
children born small, their growth and hormonal profile at birth and during the 
first 6 months after birth. To understand the difference between those who are 
born small and with normal weight, some of the normal weight  babies will also 
be part of this study. 
What will you have to do? 
If you give consent for the study, some blood tests and simple measurements 
(weight, height and head circumference) will be done for your baby at birth. Your 
baby will not be pricked for tests as these will be taken from the umbilical cord 
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blood. Both parents weight and height will be recorded. During your hospital 
visits for vaccination at 3 & 6 months,  your child will be measured by the 
Paediatrician and details of the baby’s diet will be collected. At 6 months, babies 
who were born small will have a single blood test done by the Padiatrician. 
Mothers will have their weight and height recorded once again.  
 Can you withdraw from this study after it starts? 
Your participation in this study is entirely voluntary and you are also free to 
decide to withdraw permission to participate in this study. If you do so, this will 
not affect your usual treatment at this hospital in any way.  
What will happen if you develop any study related injury? 
As the study involves usual body measurements and a simple blood test by a 
qualified Paediatrician at 6 months of age, we do not anticipate any study related 
injury to your child.   
Will you have to pay for the blood tests? 
The blood test for the study  will be done free of cost for you, however if you 
develop any unrelated illness , you will have to bear the hospital expenses. 
Will your personal details be kept confidential? 
The results of this study will be published in a medical journal but you will not be 
identified by name in any publication or presentation of results. However, your 
medical notes may be reviewed by people associated with the study, without 
your additional permission, should you decide to participate in this study. 
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Format for Informed Consent Form for Subjects 
Informed Consent form to participate in a research study  
Study Title:Correlation between cord blood insulin/IGF-1 and early postnatal growth in small 
for gestational age babies. 
 
Study Number: ____________ 
 
Subject’s Initials: __________________ Subject’s Name: _________________________________________ 
 
Date of Birth / Age: ___________________________ 
 
(Subject) 
 
(i)  I confirm that I have read and understood the information sheet dated ____________ 
for the above study and have had the opportunity to ask questions. [  ] 
 
(ii)  I understand that my participation in the study is voluntary and that I amfree to 
withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [  ] 
 
(iii)  I understand that the investigators doing the study, the Ethics Committee and the 
regulatory authorities will not need my permission to look at my health records 
both in respect of the current study and any further research that may be conducted 
in relation to it, even if I withdraw from the trial. I agree to this access. However, I 
understand that my identity will not be revealed in any information released to 
third parties or published. [  ] 
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(iv)  I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s).[  ] 
 
(v)  I agree to take part in the above study.[  ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable  
 
Date: _____/_____/______ 
 
Signatory’s Name: _________________________________Signature:  
 
Or 
 
 
 
 
 
 
 
 
Representative: _________________ 
 
Date: _____/_____/______ 
 
Signatory’s Name: _________________________________ 
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Signature of the Investigator: ________________________ 
 
Date: _____/_____/______ 
 
Study Investigator’s Name: _________________________ 
 
 
Signature or thumb impression of the Witness: ___________________________ 
 
Date: _____/_____/_______ 
 
Name & Address of the Witness: ______________________________ 
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